Health Condition 1: I60-I69- Cerebrovascular diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for unit of cluster (district hospital) 1. District hospitals where only non-stroke physicians are available 2. Physicians should have experience of using a smartphone with 24/7 internet access 3. Availability of CT scan Individual level 1. Age greater than or equal to 18 years 2. Diagnosis of acute Ischemic stroke ( 3. Provide written, informed consent to receive the intervention
Exclusion criteria
Exclusion criteria: Exclusion criteria for unit of cluster (district hospital) 1. Availability of a neurologist in the hospital 2. Lack of smart phone or internet access Individual level 1. Patients not with terminal illness 2. Not willing to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the composite score (percentage) of performance of stroke care bundle. Highest score (100%) will be achieved if all the eligible patients received the standard stroke care bundle. 24 measures are grouped into 4 bundles (acute management, in-hospital management, Discharge advice, and follow up)Timepoint: 1 month and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients achieving mRS 0-2Timepoint: 1 month and 3 months;Proportion of patients who received Aspirin within 48 hrsTimepoint: 1 month and 3 months;Proportion of patients who received Dysphagia screening testTimepoint: 1 month and 3 months;Proportion of patients who received RehabilitationTimepoint: 1 month and 3 months;Proportion of patients who received Smoking cessation counsellingTimepoint: 1 month and 3 months;Proportion of patients who received statinsTimepoint: 1 month and 3 months;Proportion of patients who received Venous thromboembolism prophylaxisTimepoint: 1 month and 3 months;Proportion of patients who were evaluated for physiotherapy within 48 hrsTimepoint: 1 month and 3 months;Proportion of patients with AF who received AnticoagulantsTimepoint: 1 month and 3 months;Proportion of patients with newly diagnosed Atrial fibrillationTimepoint: 1 month and 3 months;Proportion of patients without AF who received antipalteletsTimepoint: 1 month and 3 months | — |
Countries
India
Contacts
All India Institute of Medical Sciences, New Delhi